Advertisement
Screener

Longevity Health Holdings, Inc. (XAGE) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum

1.9 / 5 stars · 12/32 Roast Me

Longevity Health Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum

Longevity Health Holdings, Inc. (XAGE) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 4.60% for the 12-month period ending 2024-12-31, per its 10-K/A filed 2025-06-17.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2025-06-17

  • Longevity Health Holdings, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2024-03-31 was 4.30%.
  • Longevity Health Holdings, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2024 was 4.60%, a 21.05% increase from fiscal 2023.
  • Longevity Health Holdings, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2023 was 3.80%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month
2024-12-314.60%
10-K/A · filed 2025-06-17
2024-09-304.60%
10-Q · filed 2024-11-14
2024-06-304.60%
10-Q · filed 2024-08-14
2024-03-314.30%
10-Q · filed 2024-05-15
2023-12-313.80%
10-K · filed 2024-04-01
2023-09-303.75%
10-Q · filed 2023-11-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
STEPAN CO (SCL)United States$1.451B-477.05
CHURCH & DWIGHT CO INC /DE/ (CHD)United States$22.622B30.81
ECOLAB INC. (ECL)United States$77.183B36.58
PROCTER & GAMBLE Co (PG)United States$338.763B21.26